SciTransfer
Organization

Naturality Research & Development

Spanish SME specializing in graphene processing, nanopatterning, and pilot-line fabrication of advanced 2D materials for industrial applications.

Technology SMEdigitalESSMENo active H2020 projects
H2020 projects
5
As coordinator
0
Total EC funding
€877K
Unique partners
235
What they do

Their core work

Naturality Research & Development is a Spanish SME based in Terrassa (Barcelona) specializing in advanced materials processing, particularly graphene and 2D materials, with strong capabilities in nanopatterning and surface functionalization techniques. They contribute manufacturing and pilot-line expertise to large European research consortia, helping translate graphene research into scalable production processes. Their work spans from antimicrobial polymer coatings using roll-to-roll nanoimprinting to edible biosensors and microfluidic devices for health diagnostics, indicating a materials-processing company that applies its fabrication know-how across multiple application domains.

Core expertise

What they specialise in

3 projects

Core participant in GrapheneCore2, GrapheneCore3, and 2D-EPL — all part of the Graphene Flagship, Europe's largest materials research initiative.

Nanopatterning and roll-to-roll fabricationprimary
2 projects

FLEXPOL focused on thermal NIL and roll-to-roll nanoimprinting for antimicrobial polymer surfaces; this fabrication expertise likely underpins their Graphene Flagship contributions.

Biosensors and microfluidic devicesemerging
1 project

SALSETH project develops edible food-based biosensors and microfluidic chips for intraoral saliva-based diagnostics.

Antimicrobial surface coatingssecondary
1 project

FLEXPOL targeted antimicrobial flexible polymers for hospital environments using oil emulsions and nanopatterning.

Evolution & trajectory

How they've shifted over time

Early focus
Nanopatterning and polymer coatings
Recent focus
Graphene pilot-line production

In their early H2020 period (2017–2018), Naturality focused on polymer surface engineering — antimicrobial coatings, nanoimprinting, and roll-to-roll fabrication techniques. From 2019 onward, their work shifted decisively toward graphene and 2D materials at pilot-line scale, with three concurrent Graphene Flagship projects, while also branching into bio-compatible sensors and microfluidics. The trajectory shows a company moving from general nanofabrication services toward becoming a specialized graphene manufacturing partner with emerging health-tech applications.

Naturality is deepening its graphene manufacturing capabilities toward industrial pilot-line scale, positioning itself as a go-to SME partner for commercializing 2D materials in Europe.

Collaboration profile

How they like to work

Role: specialist_contributorReach: European26 countries collaborated

Naturality operates exclusively as a participant — they have never coordinated an H2020 project, which is typical for a specialist SME that contributes specific technical capabilities rather than driving research agendas. With 235 unique consortium partners across 26 countries, they are well-networked through large flagship-scale consortia (Graphene Flagship projects often include 150+ partners). This means they are experienced at integrating into complex multi-partner projects and delivering defined work packages on schedule.

Through five projects, Naturality has collaborated with 235 unique partners across 26 countries — a remarkably broad network driven primarily by participation in the massive Graphene Flagship consortia. Their geographic reach spans most of Europe, though their base in the Barcelona industrial region connects them strongly to the Spanish and Southern European advanced materials ecosystem.

Why partner with them

What sets them apart

Naturality occupies a specific niche: they are a private SME with hands-on nanofabrication and materials-processing capability embedded within Europe's flagship graphene research program. Unlike university labs that publish papers, or large companies that integrate final products, they sit in the critical middle — scaling laboratory processes toward pilot production. For consortium builders, they offer an industry partner that can handle physical fabrication of advanced materials without the overhead of a large corporate partner.

Notable projects

Highlights from their portfolio

  • GrapheneCore3
    Their largest funded project (EUR 601,250), representing deepened commitment to the Graphene Flagship as it moved toward industrial applications.
  • SALSETH
    An unusual pivot into edible biosensors and intraoral diagnostics — signals diversification of their materials expertise into health-tech applications.
  • 2D-EPL
    Participation in the Graphene Flagship's Experimental Pilot Line places them at the center of Europe's effort to industrialize 2D materials production.
Cross-sector capabilities
health diagnostics and biosensorsantimicrobial coatings for healthcareenergy applications of graphenefood-safe edible materials
Analysis note: Profile built from 5 projects with moderate detail. Three of five projects are part of the Graphene Flagship (a mega-consortium), which inflates the partner count (235) and country reach (26) beyond what a 5-project SME would typically achieve independently. Two projects show no EC funding amount, suggesting possible in-kind or third-party-like contributions. No website available for independent verification of company capabilities.